Axitan Limited, a leading biotech company focused on the development of endolysin enzyme products to replace antibiotics in animal feed, has recently announced a strategic partnership with QualiTech, a global manufacturer of animal nutrition, plant nutrition, and food ingredient products and services. This partnership will involve the development and distribution of novel endolysin products aimed at addressing pathogenic issues in the animal nutrition industry.
As part of the agreement, QualiTech will serve as the exclusive distributor for Axitan’s FORC3® product in the swine, ruminant, and poultry markets in North America, excluding broilers. Axitan will retain exclusive distribution rights for broilers. FORC3® has demonstrated significant success in targeting Clostridium perfringens, the causative agent of necrotic enteritis in poultry.
In addition to distributing FORC3® in North America, Axitan and QualiTech will collaborate on the development of new endolysin-based products to address pathogenic challenges in the swine and ruminant segments. QualiTech will have exclusive distribution rights for these new products in the swine and ruminant markets in North America.
Alfred Zimmerman, CEO of Axitan, expressed enthusiasm about the partnership, stating that endolysins represent the next generation of antibiotic-free production. He sees the collaboration with QualiTech as a significant endorsement of Axitan’s technology platform and an opportunity to leverage QualiTech’s strong presence in the North American animal nutrition market.
Axitan’s biotech team has been at the forefront of incorporating endolysins into animal feed to target and eliminate pathogens traditionally managed through antibiotics. The company’s products offer performance benefits to livestock farmers while mitigating pathogens without triggering antimicrobial resistance. FORC3® is currently in commercial production and specifically targets Clostridium perfringens in poultry. Axitan has a robust pipeline of new endolysin-based products targeting other pathogens that impact production and food safety.
Scott Hine, President of QualiTech’s Animal Nutrition and Agronomy businesses, highlighted the synergies between Axitan’s products and QualiTech’s existing solutions. He emphasized the importance of early-life vitality and performance in animal nutrition and expressed confidence in the partnership’s ability to introduce innovative, performance-enhancing, antibiotic-free feed additives to the market.
Founded in 1967 and headquartered in Chaska, MN, QualiTech is a global leader in value-added ingredient solutions for food, animal nutrition, and agronomy customers. The company focuses on delivering high-quality ingredients and nutrients that promote health and wellbeing in people, animals, and the environment. QualiTech’s commitment to providing top-notch products aligns with consumer demand for antibiotic-free, high-protein food sources.
Axitan, on the other hand, is dedicated to developing, manufacturing, and selling novel endolysins to target and neutralize pathogens affecting animal production and food safety. The company’s endolysins form the basis of its feed additive products, which aim to improve performance and eliminate pathogens without the use of antibiotics. Axitan’s mission is to facilitate the safe removal of antibiotics from animal production through endolysin-based solutions.
In conclusion, the partnership between Axitan and QualiTech represents a significant step forward in the development of innovative solutions for the animal nutrition industry. By combining their expertise and resources, the two companies are poised to lead the way in providing high-quality, antibiotic-free feed additives that support animal health and wellbeing. For more information about QualiTech and Axitan, please visit their respective websites at www.qualitechco.com and www.axitan.com.
